PRP Kit Components and How Systems Differ
What components make up a PRP kit and how do they differ between systems?
Strip away the branding and a PRP kit is a sterile, single-patient set with one job: take your patient's blood and split it into layers so you can draw off the platelet-rich fraction. Nearly every kit on the market does that with the same four parts, so when you're comparing boxes you're really only comparing two of them. Get that straight and the buying decision stops being about sticker price and starts being about what actually ends up in the syringe.
Every PRP kit is built from the same four functional parts, a vessel holding 8 mL to 60 mL of blood, a citrate anticoagulant at roughly one part to nine, a way of separating the layers, and a transfer pathway, and it's the separation method and the spin protocol that decide what you inject.
What are the standard physical components included in a single-patient PRP kit?
Open a typical box and the contents are unglamorous, and only one item inside has had real engineering spent on it. Knowing exactly where the supplied pathway stops is what keeps you from finding a missing link halfway through a procedure.
- Processing vessel: Sealed 10 mL to 22 mL tube, or a 30 mL to 60 mL syringe-style chamber.
- Draw consumables: 21 gauge butterfly or straight needle, transfer syringes, blunt cannula for retrieval.
- Anticoagulant: Citrate pre-loaded in the tube, or a separate vial you draw up first.
- Closed-transfer device: Valved connector or stopcock, often the one item separating premium from basic.
The centrifuge isn't in the box, and because every kit is validated at a stated relative centrifugal force, it only works on a rotor that can actually hit that number.
How do separator technologies such as gel barriers, buoys, and floats differ inside the processing tube?
The separator is the one component that decides which cells reach your syringe, so it's where your money genuinely goes. Gel, buoy, and bare tube each solve the same problem with a different trade between repeatability and control, and the buffy coat sits right where all three have to make their call.
| Criteria | Gel barrier | Buoy or float | No separator |
|---|---|---|---|
| Resting position | Between packed red cells and plasma | At or just under the buffy coat | None, you judge the depth |
| Buffy coat capture | Partial, depends on gel tuning | Tight, banded into a narrow zone | Variable, set by draw depth |
| Skill demand | Low | Low to moderate | High |
| Quiet failure mode | Short spin leaves gel unmigrated | Buoy stops short of position | Red cell carryover |
A buoy or two-part float isolates the buffy coat most tightly, a gel barrier gives the cleanest pour but traps a share of platelets beneath it when it's tuned slightly high, and a separator-free tube hands the entire decision to your draw depth.
Which anticoagulants are supplied with PRP kits and how does the choice affect the final product?
Citrate isn't the anticoagulant of habit, it's the anticoagulant of mechanism. It locks up ionised calcium, which parks the platelets rather than spending them, and adding calcium back later hands you the clotting pathway again exactly where you want it. That reversibility is the whole reason heparin doesn't belong in this workflow.
Citrate is used at roughly one part to nine parts whole blood, and under-filling a pre-loaded tube silently changes that ratio because the citrate volume inside is fixed.
What distinguishes a closed processing system from an open one during preparation?
Closed means the blood never meets room air, and open means the circuit gets broken at least once, usually when you uncap a tube on the bench. Plenty of clinics have run open tube kits for years without incident, so this is about controlling one specific hazard, not about calling a system unsafe.
| Criteria | Closed system | Open system |
|---|---|---|
| Air exposure | None, sealed from vein to syringe | Seal broken at least once after the spin |
| Contamination risk | Lower, and it doesn't climb with handling | Small per procedure, rises with each uncapping |
| Cost per kit | Higher | Lower |
| Harvest flexibility | Locked to the designer's geometry | You set the draw depth on the day |
A closed pathway buys consistency and removes one specific contamination route, but it never substitutes for aseptic technique, and good technique carries an open system safely.
How do single-spin and double-spin kits differ in what they contain and what they produce?
Most people hear "double spin" and assume it's simply the better one, but the two spins are doing opposite jobs. The first is deliberately gentle so the platelets stay suspended up in the plasma; the second is hard, because now you want them pelleted. What changes in the box is small, and what changes in the syringe is not.
- Soft spin: Low force for a few minutes packs the red cells down and leaves the platelets in the plasma above.
- Decision point: Stop here and you've got a single-spin product, a generous volume at modest concentration.
- Hard spin: Move the plasma to a second sterile vessel and spin at higher force to pellet the platelets.
- Resuspension: Discard most of the platelet-poor supernatant and resuspend the pellet in a few millilitres.
A double-spin kit has to include a second sterile vessel, an extra transfer device, and clearer graduations, and it trades roughly five to ten extra minutes plus a real risk of shearing platelets for a smaller, denser final volume.
How do kits differ in the leukocyte content of the concentrate they produce?
Any decision about how hard you chase the buffy coat is also a decision about white cells, whether the manufacturer frames it that way or not. That's why two clinics running identical boxes can be injecting materially different products. Your harvest technique is as much a variable here as the kit you bought.
- Leukocyte-rich harvest: Buoy, two-part float, or a draw taken right down to the red cell interface.
- Leukocyte-poor harvest: Plasma taken above a conservatively set gel barrier or a cautious manual draw.
- Neutrophils: Release proteases and reactive oxygen species that can drive local inflammation.
- Mononuclear cells: Monocytes and lymphocytes that support matrix remodelling and recruit repair.
The same tube can produce either a leukocyte-rich or a leukocyte-poor preparation depending on harvest depth, so the only way to know what your own hands produce is a complete blood count on both the whole blood and the concentrate.
How much whole blood does a kit require and how much usable concentrate does it yield?
Draw volumes cluster into recognisable bands, and yield doesn't come off them in any simple ratio. Size the draw to the treatment area and the protocol, because taking more blood than you'll use costs your patient comfort and buys you nothing.
Platelet recovery efficiency, the share of the whole blood's platelets that reach the final product, describes a kit better than concentration factor does, since a high factor in a tiny volume can hold no more total platelets than a gentler protocol.
What regulatory clearances apply to the devices used to prepare platelet concentrates?
Here's the gap that gets clinics into trouble: regulators assess these products as devices for processing a blood sample, not as treatments. A clearance tells you the kit separates plasma comparably to something already on the market, and it tells you nothing about whether the therapy works. Treat that line as the boundary of what you're allowed to say.
A substantial equivalence clearance states only that the device performs comparably to one already on the market for preparing a platelet concentrate, and a cleared kit's labelling can carry an explicit limit on how the separated components may be used.
What equipment and supplies does a clinic need beyond the kit itself to complete a treatment?
The centrifuge is what turns a box of disposables into a working setup, and it isn't interchangeable. Everything surrounding the draw and the delivery comes off your own shelves, so walk the whole procedure through on paper once before you order.
- Matched centrifuge: Force depends on rotor radius as well as rpm, so the same rpm on another machine isn't the same spin.
- Draw station: Tourniquet, antiseptic prep, gloves, gauze, sharps container, and a clean dedicated surface for any open transfer.
- Delivery set: Needle gauge and length chosen for the target, with ultrasound guidance for deeper structures.
- Comfort measures: Topical or local anaesthetic, plus any cooling or vibration device you use.
- Activation, if your protocol calls for it: Calcium chloride, calcium gluconate, or thrombin added at the point of use.
- Waste and records: A compliant sharps and biohazard stream, plus kit lot numbers traceable to the patient.
Running a kit on an unvalidated centrifuge voids the performance data that came with it, because rotor radius changes the actual force delivered and fixed-angle and swing-out rotors lay the layers down at different geometries.
What drives the price difference between one kit and another?
Prices span roughly an order of magnitude, and only part of that spread is explained by what's physically in the box. Some of it is real manufacturing and validation cost, and some of it is positioning. Work backwards from the product your treatment actually needs and you'll spend the difference where it returns something.
The disposable is usually a modest fraction of what a session costs once you count clinician time, room time, anaesthetic, and the centrifuge you already paid for, so one inconsistent kit that forces a second draw erases its saving several times over.
